Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Prostate diseases

Automated counting of prostate cell types with image processing and machine learning

Babak Kamali Doust Azad, Aryan Norouzzadeh Hakimi, [ ... ], Mohammadreza Kolahdouz

Unraveling the role of ChREBP in lung adenocarcinoma: Expression, regulatory networks, and potential functional impact

Athisake Ruangpracha, Chanachai Sae-Lee, [ ... ], Naravat Poungvarin

A survivorship-oriented enhanced care model for patients undergoing radical prostatectomy

Xiuqun Yuan, Yuting Chen, [ ... ], Xia Sheng

Differential sensitivity of MCPH1- and BRCA2-deficient cancer cells to PARP-1 inhibition

Isobel G. Chapman, Xueqin Wu, Stephany Veuger, Paul A. Jowsey

CAPG serves as a prognostic biomarker and promotes proliferation and migration in pancreatic ductal adenocarcinoma

Zhongyu Qin, Kaixia Li, [ ... ], Yiqiang Zhang

Prostate cancer tissue mapping and stratification using DRAQ5 and Eosin fluorescent labels integrated with AI classification and segmentation algorithms

Michail Georgios Papachristos, Emiliano Spezi, [ ... ], Dimitris Parthimos

Voiding symptoms aggravate with decreasing stromal/epithelial ratio and increasing glandular-epithelial content in patients undergoing laser enucleation for benign prostatic hyperplasia, independently from prostate size

Patrick Keller, Sheng Hu, [ ... ], Martin Hennenberg

LM-UNet: Lightweight Mamba-UNet Prostate MRI image segmentation network

Kuncai Xu, Shuai Zhou, [ ... ], Yilong Liao

Cancer risk associated with DPP4 inhibitors in type 2 diabetes: A pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS)

Wan Xiong, Yilin Li, [ ... ], Ji Sun

Enhancing cancer drug discovery: QSAR modeling with machine learning and chemical representations

Raúl Acosta-Murillo, José Carlos Ortiz-Bayliss, Patricio Adrian Zapata-Morin

Multiple omics analyses and experiments validation identify PRDX3 as a biomarker of prognosis and antioncogene in kidney clear cell carcinoma

Yanyan Li, Xiangyuan Tan, Zhanzhan Li, Peng Chen

Multi-omics analysis identifies CCNB1 as a cell cycle factor driving glioblastoma progression and its inhibition by resveratrol

Bohan Liu, Dazhao Peng, [ ... ], Huimin Hu

Measuring representation in clinical trials: Simulations demonstrating how current methods fail in the context of precision medicine

Andrew Friedson, Abigail Humphreys, June Cha

Advertisement

Create a weekly email alert for: Prostate diseases

You can change these options by clicking profile then "Alerts and Notifications"